These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21986021)

  • 1. Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients.
    Tüzün E; Yılmaz V; Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Med Princ Pract; 2011; 20(6):581-3. PubMed ID: 21986021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
    Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
    Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
    Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis.
    Stascheit F; Chuquisana O; Keller CW; Ambrose PA; Hoffmann S; Gross CC; Lehnerer S; Wiendl H; Willcox N; Meisel A; Lünemann JD
    Eur J Neurol; 2023 May; 30(5):1409-1416. PubMed ID: 36752022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
    Chan KH; Lachance DH; Harper CM; Lennon VA
    Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different characteristic phenotypes according to antibody in myasthenia gravis.
    Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.